Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01949324 · ClinicalTrials.gov registry record · Phase 2
A Phase 2 Multicenter Randomized Clinical Trial of CNTF for MacTel
A Phase 2 study, sponsored by Neurotech Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 67
- Enrollment target
NCT01949324 is a Phase 2 study that has completed, run by Neurotech Pharmaceuticals. The registered enrollment target is 67 participants.
The verdict
NCT01949324, a Phase 2 study, has completed, sponsored by Neurotech Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 67 participants
- Enrollment target
Study Summary
This study is a phase 2, randomized, multi-center, single-masked study to evaluate the efficacy and safety of the NT-501 implants in participants with Mactel.
Interventions
- PROCEDURE Sham procedure
- BIOLOGICAL Ciliary neurotrophic factor (CNTF)
- DEVICE NT-501 Implant
- PROCEDURE NT-501 Implant procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2014-04 |
| Est. Completion | 2017-05-22 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01949324
The ClinicalTrials.gov registry entry for NCT01949324 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Neurotech Pharmaceuticals, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Sham procedure is the first listed.
NCT01949324 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01949324 about?
NCT01949324 is a clinical study titled "A Phase 2 Multicenter Randomized Clinical Trial of CNTF for MacTel". This study is a phase 2, randomized, multi-center, single-masked study to evaluate the efficacy and safety of the NT-501 implants in participants with Mactel.
What is the current status of trial NCT01949324?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 67 participants. The study started on 2014-04. Estimated completion is 2017-05-22.
What interventions are being tested in trial NCT01949324?
The interventions under investigation include: Sham procedure (PROCEDURE), Ciliary neurotrophic factor (CNTF) (BIOLOGICAL), NT-501 Implant (DEVICE), NT-501 Implant procedure (PROCEDURE).
Who is sponsoring clinical trial NCT01949324?
This trial is sponsored by Neurotech Pharmaceuticals, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.